인성크로마텍 로고

검색버튼
퀵메뉴 펼침

o
p
e
n
c
l
o
s
e

RemiBridge ELISA (for Remicade Biosimilar comparison)
제품명: RemiBridge ELISA (for Remicade Biosimilar comparison)
용도: mAb Conformational Analysis
메이커: ArrayBridge
카달로그:


소개

 

RemiBridge ELISA    For Remicade Biosimilar comparison 


Complete kit for the systematic 3-D conformational comparability analysis of ArrayELISA1C__16559.1384998687.1280.1280.jpg

Remicade biosimilar molecule to Infliximab (Remicade trade name)


Infliximab is a chimeric monoclonal antibody against tumor necrosis factor-alpha (TNF-α). TNF-α is a cytokine, or chemical messenger, and a key part of the autoimmune reaction. Infliximab was first approved by the FDA in 1998 for the treatment of Crohn’s disease. It has subsequently been approved for use in treating psoriasis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. 


This kit will allow for conformational (Higher-Order Structure) comparison between Remicade Biosimilars and authentic Infliximab. 


주문정보

AB000209       RemiBridge ELISA (for Remicade Biosimilar comparison)      1 Kit

관련자료